Sandoz, Pfizer Fail to Escape Skin Care Drug Price-Fixing Claims

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals LLC are among 36 drugmakers that will face claims from states that companies colluded to fix the price of generic skin care products and forced consumers to pay higher prices.

Judge Michael P. Shea of the US District Court for the District of Connecticut on Oct. 31 denied the drugmakers’ joint motion for summary judgment, saying the claims aren’t time-barred under the Sherman Act’s four-year statute of limitations.

“I agree with the States that, under the continuing violation doctrine as construed in the Second Circuit, their claims alleging price fixing are timely,” ...